GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Fundamental Analysis

NYSE:GRDN • US40145W1018

33.54 USD
+0.5 (+1.51%)
At close: Feb 20, 2026
33.54 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

GRDN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. GRDN has only an average score on both its financial health and profitability. GRDN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year GRDN was profitable.
  • In the past year GRDN had a positive cash flow from operations.
  • Of the past 5 years GRDN 4 years were profitable.
  • GRDN had a positive operating cash flow in each of the past 5 years.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • GRDN has a better Return On Assets (10.32%) than 93.14% of its industry peers.
  • Looking at the Return On Equity, with a value of 21.90%, GRDN belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
  • GRDN has a Return On Invested Capital of 20.33%. This is amongst the best in the industry. GRDN outperforms 94.12% of its industry peers.
Industry RankSector Rank
ROA 10.32%
ROE 21.9%
ROIC 20.33%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • GRDN has a Profit Margin of 2.90%. This is in the better half of the industry: GRDN outperforms 66.67% of its industry peers.
  • GRDN has a better Operating Margin (4.22%) than 60.78% of its industry peers.
  • Looking at the Gross Margin, with a value of 19.74%, GRDN is in line with its industry, outperforming 42.16% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GRDN has remained more or less at the same level.
Industry RankSector Rank
OM 4.22%
PM (TTM) 2.9%
GM 19.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GRDN is creating value.
  • GRDN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GRDN has been increased compared to 5 years ago.
  • GRDN has a better debt/assets ratio than last year.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 10.42 indicates that GRDN is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 10.42, GRDN belongs to the top of the industry, outperforming 95.10% of the companies in the same industry.
  • GRDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.42
ROIC/WACC2.33
WACC8.74%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

  • A Current Ratio of 1.22 indicates that GRDN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.22, GRDN is in line with its industry, outperforming 44.12% of the companies in the same industry.
  • GRDN has a Quick Ratio of 1.22. This is a bad value and indicates that GRDN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GRDN has a worse Quick ratio (0.93) than 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.93
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 139.38% over the past year.
  • Looking at the last year, GRDN shows a very negative growth in Revenue. The Revenue has decreased by -28.22% in the last year.
  • GRDN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.96% yearly.
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.35% on average over the next years. This is a very strong growth
  • GRDN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.73% yearly.
EPS Next Y158.33%
EPS Next 2Y69.19%
EPS Next 3Y43.76%
EPS Next 5Y33.35%
Revenue Next Year17.72%
Revenue Next 2Y8.39%
Revenue Next 3Y8.91%
Revenue Next 5Y8.73%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 53.24, the valuation of GRDN can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as GRDN.
  • GRDN is valuated expensively when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 31.77, which means the current valuation is very expensive for GRDN.
  • The rest of the industry has a similar Price/Forward Earnings ratio as GRDN.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, GRDN is valued at the same level.
Industry RankSector Rank
PE 53.24
Fwd PE 31.77
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GRDN is on the same level as its industry peers.
  • GRDN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 31.15
EV/EBITDA 25.55
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • GRDN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of GRDN may justify a higher PE ratio.
  • A more expensive valuation may be justified as GRDN's earnings are expected to grow with 43.76% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y69.19%
EPS Next 3Y43.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for GRDN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (2/20/2026, 8:04:00 PM)

After market: 33.54 0 (0%)

33.54

+0.5 (+1.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-10
Earnings (Next)03-11
Inst Owners57.53%
Inst Owner Change2.39%
Ins Owners8.89%
Ins Owner Change74.94%
Market Cap2.12B
Revenue(TTM)1.39B
Net Income(TTM)40.24M
Analysts86
Price Target35.7 (6.44%)
Short Float %8.32%
Short Ratio6.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.47%
Min EPS beat(2)-13.49%
Max EPS beat(2)-11.45%
EPS beat(4)1
Avg EPS beat(4)-7.59%
Min EPS beat(4)-18.3%
Max EPS beat(4)12.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)2.36%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.94%
PT rev (3m)20.69%
EPS NQ rev (1m)11.94%
EPS NQ rev (3m)20.97%
EPS NY rev (1m)-9.48%
EPS NY rev (3m)4.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.73%
Valuation
Industry RankSector Rank
PE 53.24
Fwd PE 31.77
P/S 1.53
P/FCF 31.15
P/OCF 24.14
P/B 11.56
P/tB 24.91
EV/EBITDA 25.55
EPS(TTM)0.63
EY1.88%
EPS(NY)1.06
Fwd EY3.15%
FCF(TTM)1.08
FCFY3.21%
OCF(TTM)1.39
OCFY4.14%
SpS21.95
BVpS2.9
TBVpS1.35
PEG (NY)0.34
PEG (5Y)N/A
Graham Number6.41
Profitability
Industry RankSector Rank
ROA 10.32%
ROE 21.9%
ROCE 25.73%
ROIC 20.33%
ROICexc 24.2%
ROICexgc 49.8%
OM 4.22%
PM (TTM) 2.9%
GM 19.74%
FCFM 4.91%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
F-Score6
Asset Turnover3.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 91.13%
Cap/Sales 1.43%
Interest Coverage 75.25
Cash Conversion 109.39%
Profit Quality 169.42%
Current Ratio 1.22
Quick Ratio 0.93
Altman-Z 10.42
F-Score6
WACC8.74%
ROIC/WACC2.33
Cap/Depr(3y)87.95%
Cap/Depr(5y)73.67%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
EPS Next Y158.33%
EPS Next 2Y69.19%
EPS Next 3Y43.76%
EPS Next 5Y33.35%
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%
Revenue Next Year17.72%
Revenue Next 2Y8.39%
Revenue Next 3Y8.91%
Revenue Next 5Y8.73%
EBIT growth 1Y251.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year264.98%
EBIT Next 3Y58.03%
EBIT Next 5Y43.45%
FCF growth 1Y-26.08%
FCF growth 3Y-5.46%
FCF growth 5Y-0.01%
OCF growth 1Y-18.16%
OCF growth 3Y-0.31%
OCF growth 5Y0.63%

GUARDIAN PHRMCY SERVICES-A / GRDN FAQ

Can you provide the ChartMill fundamental rating for GUARDIAN PHRMCY SERVICES-A?

ChartMill assigns a fundamental rating of 5 / 10 to GRDN.


What is the valuation status of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

ChartMill assigns a valuation rating of 4 / 10 to GUARDIAN PHRMCY SERVICES-A (GRDN). This can be considered as Fairly Valued.


How profitable is GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

GUARDIAN PHRMCY SERVICES-A (GRDN) has a profitability rating of 6 / 10.


What is the financial health of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

The financial health rating of GUARDIAN PHRMCY SERVICES-A (GRDN) is 6 / 10.